ATE284399T1 - Chinolinpropyl-piperidinderivate und deren verwendung als antibakterielle wirkstoffe - Google Patents

Chinolinpropyl-piperidinderivate und deren verwendung als antibakterielle wirkstoffe

Info

Publication number
ATE284399T1
ATE284399T1 AT00962637T AT00962637T ATE284399T1 AT E284399 T1 ATE284399 T1 AT E284399T1 AT 00962637 T AT00962637 T AT 00962637T AT 00962637 T AT00962637 T AT 00962637T AT E284399 T1 ATE284399 T1 AT E284399T1
Authority
AT
Austria
Prior art keywords
quinolinepropyl
active ingredients
piperidine derivatives
antibacterial active
antibacterial
Prior art date
Application number
AT00962637T
Other languages
English (en)
Inventor
Jean-Luc Malleron
Michel Tabart
Jean-Christophe Carry
Michel Evers
Ahmad Youssef El
Serge Mignani
Fabrice Viviani
Michel Cheve
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE284399T1 publication Critical patent/ATE284399T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT00962637T 1999-09-17 2000-09-14 Chinolinpropyl-piperidinderivate und deren verwendung als antibakterielle wirkstoffe ATE284399T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9911679A FR2798656B1 (fr) 1999-09-17 1999-09-17 Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
PCT/FR2000/002541 WO2001025227A2 (fr) 1999-09-17 2000-09-14 Derives de la quinolyl propyl piperidine et leur utilisation en tant que antibacteriens

Publications (1)

Publication Number Publication Date
ATE284399T1 true ATE284399T1 (de) 2004-12-15

Family

ID=9549990

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00962637T ATE284399T1 (de) 1999-09-17 2000-09-14 Chinolinpropyl-piperidinderivate und deren verwendung als antibakterielle wirkstoffe

Country Status (30)

Country Link
EP (2) EP1218370B1 (de)
JP (1) JP2004527448A (de)
KR (1) KR20020038757A (de)
CN (1) CN1374959A (de)
AP (1) AP2002002459A0 (de)
AT (1) ATE284399T1 (de)
AU (1) AU7429500A (de)
BG (1) BG106524A (de)
BR (1) BR0014060A (de)
CA (1) CA2383836A1 (de)
CZ (1) CZ2002940A3 (de)
DE (2) DE60034713T2 (de)
DZ (1) DZ3195A1 (de)
EA (1) EA005183B1 (de)
EE (1) EE200200138A (de)
FR (1) FR2798656B1 (de)
GE (1) GEP20043223B (de)
HR (1) HRP20020214A2 (de)
HU (1) HUP0204283A3 (de)
IL (1) IL148720A0 (de)
MA (1) MA26820A1 (de)
MX (1) MXPA02001979A (de)
NO (1) NO20021253L (de)
OA (1) OA12022A (de)
PL (1) PL354809A1 (de)
SK (1) SK3632002A3 (de)
TN (1) TNSN00184A1 (de)
WO (1) WO2001025227A2 (de)
YU (1) YU19002A (de)
ZA (1) ZA200202073B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822440D0 (en) 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB9917408D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
GB9917406D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
NZ523749A (en) 2000-07-26 2005-03-24 Smithkline Beecham P Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
GB0031086D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
US7312212B2 (en) 2002-01-29 2007-12-25 Glaxo Group Limited Aminopiperidine derivatives
WO2003064431A2 (en) 2002-01-29 2003-08-07 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
FR2842807A1 (fr) * 2002-07-23 2004-01-30 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, procede et intermediaires de preparation et compositions les renfermant
FR2844270B1 (fr) * 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
EP1551829B1 (de) * 2002-10-10 2010-04-07 Morphochem Aktiengesellschaft Für Kombinatorische Chemie Neue verbindungen mit antibakterieller aktivität
ES2340484T3 (es) 2002-11-05 2010-06-04 Glaxo Group Limited Agentes antibacterianos.
AU2003291227A1 (en) 2002-11-05 2004-06-07 Smithkline Beecham Corporation Antibacterial agents
ATE411312T1 (de) 2002-12-04 2008-10-15 Glaxo Group Ltd Chinoline und stickstoffhaltige derivatedavon und deren verwendung als antibakterielle mittel
EP1799674B1 (de) * 2004-10-05 2010-05-05 Actelion Pharmaceuticals Ltd. Neue piperidin-antibiotika
DE602005021133D1 (de) * 2004-10-05 2010-06-17 Actelion Pharmaceuticals Ltd Neue piperidin-antibiotika
EP1845995A4 (de) 2005-01-25 2010-03-03 Glaxo Group Ltd Antibakterielle wirkstoffe
JP2008528588A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
EP1846416A4 (de) 2005-01-25 2009-07-01 Glaxo Group Ltd Antibakterielle wirkstoffe
WO2006081264A1 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
CN101374831B (zh) 2006-01-26 2011-04-27 埃科特莱茵药品有限公司 四氢吡喃抗生素
DE602007009205D1 (de) 2006-04-06 2010-10-28 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (de) 2007-05-18 2008-11-19 Glaxo Group Limited Derivate und Analoge von N-Ethylquinolonen und N-Ethylazaquinolonen
AU2008249745B2 (en) * 2007-05-09 2012-01-12 Pfizer Inc. Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
EP2080761A1 (de) 2008-01-18 2009-07-22 Glaxo Group Limited Verbindungen
EP2352734A1 (de) 2008-10-17 2011-08-10 Glaxo Group Limited Als antibakterielle mittel verwendete tricyclische stickstoffverbindungen
WO2010081874A1 (en) 2009-01-15 2010-07-22 Glaxo Group Limited Naphthyridin-2 (1 h)-one compounds useful as antibacterials
US9663486B2 (en) * 2013-10-14 2017-05-30 Eisai R&D Management Co., Ltd. Selectively substituted quinoline compounds
CA2958800C (en) 2014-08-22 2020-10-27 Glaxosmithkline Intellectual Property Development Limited Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
MX2021006804A (es) 2015-12-17 2023-01-13 Merck Patent Gmbh Antagonistas policiclicos del receptor 7/8 tipo toll (tlr7/8) y uso de los mismos en el tratamiento de trastornos inmunitarios.
EP4198031A1 (de) 2016-08-08 2023-06-21 Merck Patent GmbH Tlr7/8-antagonisten und verwendungen davon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69908555T2 (de) * 1998-01-26 2004-05-06 Smithkline Beecham P.L.C., Brentford Chinolinderivate als antibakterielles arzneimittel
JP2002535323A (ja) * 1999-01-20 2002-10-22 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー プロテインキナーゼ阻害剤としてのピペリジニルキノリン

Also Published As

Publication number Publication date
PL354809A1 (en) 2004-02-23
YU19002A (sh) 2005-06-10
ZA200202073B (en) 2003-08-27
MA26820A1 (fr) 2004-12-20
MXPA02001979A (es) 2002-08-20
EA005183B1 (ru) 2004-12-30
EP1218370B1 (de) 2004-12-08
GEP20043223B (en) 2004-04-26
FR2798656B1 (fr) 2004-12-17
TNSN00184A1 (fr) 2005-11-10
EP1484328B1 (de) 2007-05-02
CN1374959A (zh) 2002-10-16
WO2001025227A2 (fr) 2001-04-12
OA12022A (fr) 2006-04-19
BR0014060A (pt) 2002-05-21
SK3632002A3 (en) 2003-04-01
NO20021253D0 (no) 2002-03-13
EA200200374A1 (ru) 2002-10-31
WO2001025227A3 (fr) 2001-11-22
FR2798656A1 (fr) 2001-03-23
NO20021253L (no) 2002-04-24
HUP0204283A3 (en) 2004-07-28
JP2004527448A (ja) 2004-09-09
DE60034713D1 (de) 2007-06-14
DE60016611D1 (de) 2005-01-13
IL148720A0 (en) 2002-09-12
CZ2002940A3 (cs) 2002-07-17
DZ3195A1 (fr) 2001-04-12
HRP20020214A2 (en) 2005-04-30
KR20020038757A (ko) 2002-05-23
EP1218370A2 (de) 2002-07-03
EE200200138A (et) 2003-06-16
CA2383836A1 (fr) 2001-04-12
DE60016611T2 (de) 2005-12-22
AU7429500A (en) 2001-05-10
EP1484328A1 (de) 2004-12-08
AP2002002459A0 (en) 2002-06-30
HUP0204283A2 (hu) 2003-04-28
DE60034713T2 (de) 2008-01-17
BG106524A (en) 2003-01-31

Similar Documents

Publication Publication Date Title
DE60034713D1 (de) Chinolyl-propyl-piperidinderivate und deren Verwendung als antimikrobielle Wirkstoffe
ATE490240T1 (de) Mutilinderivate und deren verwendung als antimikrobielle agenzien
DE60034683D1 (de) 3(5)-ureido-pyrazolderivate, deren herstellungsverfahren und verwendung als krebshemmende mittel
DE60003938D1 (de) Wirkstoffe in hydrogel-mikroperlen
DE59803292D1 (de) Triazolverbindungen und deren verwendung als dopamin-d 3-liganden
EE200200251A (et) Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
DE69826704D1 (de) Pleuromutlin-derivate als antimikrobielles wirkungsmittel
DE50008597D1 (de) Thiazolylharnstoff-derivate und ihre verwendung als antivirale mittel
ATE312613T1 (de) Niedrig dosierte entecavir formulierung und deren verwendung
DE69720194D1 (de) Piperazinonphenyloxazolidinon derivate und ihre verwendung als antibakterielle mittel
ATE348805T1 (de) 2-acyl-indolderivate und deren verwendung als antitumormittel
DE60010538D1 (de) Kosmetische Tensid-Präparate und deren Verwendung
DE60022828D1 (de) Kosmetikeinheit und deren Zusammensetzung
ATE259362T1 (de) Indolylpiperidinderivate als antihistaminische und antiallergische mittel
AU5146500A (en) Absorbent article with skin care composition
ATE261959T1 (de) Substituierte phenyl-piperazin-derivate, deren herstellung und verwendung
ATE326452T1 (de) Piperidinyloxy- und pyrrolidinyloxyphenyloxazolidinone als antibakterielle mittel
ATE242197T1 (de) 3-amino-3-arylpropan-1-ol-derivate, deren herstellung und verwendung
ATE300525T1 (de) Uracilverbindungen und deren verwendung
DE60005690D1 (de) Titanverbindungen, deren herstellung und verwendung
DE69524871D1 (de) Benzopyrans und deren verwendung als therapeutische mittel
DE60008807D1 (de) Binaphtol-monophosphorsäurederivate und deren Verwendung
NO20016147D0 (no) Biologiske aktive materialer
DE60001266D1 (de) Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung
DE60005514D1 (de) Dormanz-brechende zusammenstezung und deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties